Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-04

FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE from Taro Pharmaceuticals U.S.A., Inc., adding a generic enalapril/hyd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalapril Maleate and Hydrochlorothiazide (enalapril maleate and hydrochlorothiazide)

Snippet

SUPPL AP for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)